{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:52:03Z","timestamp":1761580323695},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1995,10,1]],"date-time":"1995-10-01T00:00:00Z","timestamp":812505600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Autonomic Research"],"published-print":{"date-parts":[[1995,10]]},"DOI":"10.1007\/bf01818888","type":"journal-article","created":{"date-parts":[[2005,6,27]],"date-time":"2005-06-27T18:14:14Z","timestamp":1119896054000},"page":"251-255","source":"Crossref","is-referenced-by-count":21,"title":["Neurally mediated syncope and serotonin reuptake inhibitors"],"prefix":"10.1007","volume":"5","author":[{"given":"D.","family":"Samoil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. P.","family":"Grubb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01818888_CR1","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0021-9258(18)57137-4","volume":"176","author":"MM Raport","year":"1948","unstructured":"Raport MM, Green AA, Page IH. Serum vasoconstrictor (serotonin) IV. Isolation and characterization.J Biol Chem 1948;176: 1243\u20131251.","journal-title":"J Biol Chem"},{"key":"BF01818888_CR2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.7326\/0003-4819-73-4-607","volume":"73","author":"A Sjoerdsma","year":"1970","unstructured":"Sjoerdsma A, Luvenberg W, Engelman K, Carpenter Jr WT, Wyatt RJ, Gassa JL. Serotonin now; clinical implications of inhibiting its synthesis with parachlorophenylalanine.Ann Intern Med 1970;73: 607\u2013629.","journal-title":"Ann Intern Med"},{"issue":"suppl. 2","key":"BF01818888_CR3","first-page":"421","volume":"6","author":"HO Kalkman","year":"1984","unstructured":"Kalkman HO, Engel G, Hoyer D. Three distinct types of serotonergic receptors mediate the triphasic blood pressure response to serotonin in rats.J Hypertens 1984;6 (suppl. 2): S421\u2013428.","journal-title":"J Hypertens"},{"key":"BF01818888_CR4","first-page":"191","volume-title":"Cardiovascular Pharmacology of 5-Hydroxytryptamine, Prospective Therapeutic Applications","author":"DS McQueen","year":"1990","unstructured":"McQueen DS. Cardiovascular reflexes and 5-hydroxytryptamine. In: Saxena PR, Walis DI, Wouters W, Bevan P, eds.Cardiovascular Pharmacology of 5-Hydroxytryptamine, Prospective Therapeutic Applications. Dordrecht: Kluwer Academic Publishers, 1990; 191\u2013210."},{"key":"BF01818888_CR5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0165-6147(93)90016-D","volume":"14","author":"PPA Humphrey","year":"1993","unstructured":"Humphrey PPA, Hortig P, Hoyer D. A proposed new nomenclature for 5-HT receptors.Trends Pharmacol Sci 1993;14: 233\u2013238.","journal-title":"Trends Pharmacol Sci"},{"key":"BF01818888_CR6","first-page":"173","volume":"6","author":"PR Saxena","year":"1986","unstructured":"Saxena PR. Nature of the 5-hydroxytryptamine receptors in mammalian heart.Prog Pharmacol 1986;6: 173\u2013185.","journal-title":"Prog Pharmacol"},{"key":"BF01818888_CR7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/978-94-009-0479-8_8","volume-title":"Cardiovascular Pharmacology of 5-Hydroxytryptamine, Prospective Therapeutic Applications","author":"JR Fozard","year":"1990","unstructured":"Fozard JR. Agonists and antagonists at 5-HT3 receptors. In: Saxena PR, Wallis DI, Wouters W, Bevan P, eds.Cardiovascular Pharmacology of 5-Hydroxytryptamine, Prospective Therapeutic Applications. Dordrecht: Kluwer Academic Publishers, 1990; 101\u2013116."},{"key":"BF01818888_CR8","first-page":"287","volume":"324","author":"JM Nueten Van","year":"1984","unstructured":"Van Nueten JM, Leysen JE, deClerk F, Vanhoutte PM. Serotonergic receptor subtypes and vascular reactivity.J Cardiovasc Pharmacol 1984;324: 287\u2013292.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BF01818888_CR9","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000138033","volume":"29","author":"E Glusa","year":"1984","unstructured":"Glusa E, Markwardt F. Studies on 5-hydroxytryptamine receptors on isolated human femoral veins and arteries and the influence of dihydroergotamine.Pharmacology 1984;29: 336\u2013342.","journal-title":"Pharmacology"},{"key":"BF01818888_CR10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1126\/science.6574604","volume":"221","author":"RA Cohen","year":"1983","unstructured":"Cohen RA, Shepherd JT, Vanhoutte PM. Inhibitory role of the endothelium in the response of isolated coronary arteries to platelets.Science 1983;221: 273\u2013274.","journal-title":"Science"},{"key":"BF01818888_CR11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1161\/01.HYP.2.3.243","volume":"2","author":"MD Kuhn","year":"1980","unstructured":"Kuhn MD, Wolf WA, Lovenberg W. Review of the role of central serotonergic neuronal system in blood pressure regulation.Hypertension 1980;2: 243\u2013255.","journal-title":"Hypertension"},{"key":"BF01818888_CR12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF00966020","volume":"2","author":"JL Lexchin","year":"1977","unstructured":"Lexchin JL, Cude-Simpson KD, Stancer HC. Brain and blood indole metabolites after peripheral administration of14C-5-HT in rat.Neurochem Res 1977;2: 39.","journal-title":"Neurochem Res"},{"key":"BF01818888_CR13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0024-3205(78)90267-9","volume":"23","author":"JFM Smits","year":"1978","unstructured":"Smits JFM, Van Essen H, Struyker-Boudier HAJ. Serotonin-mediated cardiovascular responses to electrical stimulation of the raphe nuclei in the rat.Life Sci 1978;23: 173.","journal-title":"Life Sci"},{"key":"BF01818888_CR14","first-page":"97","volume-title":"Serotonin, CNS Receptors and Brain Function","author":"LA Mamounas","year":"1992","unstructured":"Mamounas LA, Wilson MA, Axt KJ, Molliver ME. Morphological aspects of serotonergic innervation. In: Bradley PB, Handley SL, Cooper SJ, Key BJ, Barnes NM, Coote JM, (eds).Serotonin, CNS Receptors and Brain Function. New York: Pergamon Press, 1992; 97\u2013118."},{"key":"BF01818888_CR15","first-page":"100","volume-title":"Central Serotonin Receptors and Psychotropic Drugs","author":"D Hoyer","year":"1992","unstructured":"Hoyer D, Palacios JM, Mengod G. 5-HT receptor distribution in the human brain: autoradiographic studies. In: Marsdon CA, Heal DJ, eds.Central Serotonin Receptors and Psychotropic Drugs. Oxford: Blackwell, 1992; 100\u2013125."},{"issue":"1","key":"BF01818888_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00965820","volume":"16","author":"S El Mestikawy","year":"1991","unstructured":"El Mestikawy S, Fargin A, Raymond JR, Gozlan H, Hnatowich M. The 5-HT1 receptor: an overview of recent advances.Neurochem Res 1991;16 (1): 1\u201310.","journal-title":"Neurochem Res"},{"issue":"suppl. 7","key":"BF01818888_CR17","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1097\/00005344-199001001-00010","volume":"15","author":"AG Ramage","year":"1990","unstructured":"Ramage AG. Influence of 5-HT1A receptor agonists on sympathetic and parasympathetic nerve activity.J Cardiovasc Pharmacol 1990;15 (suppl. 7): S75-S85.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BF01818888_CR18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0028-3908(75)90010-6","volume":"14","author":"T Baum","year":"1975","unstructured":"Baum T, Shropshire AT. Inhibition of efferent sympathetic nerve activity by 5-hydroxytryptophan and centrally administered 5-hydroxytryptamine.Neuropharmacology 1975;14: 227\u2013233.","journal-title":"Neuropharmacology"},{"issue":"3","key":"BF01818888_CR19","first-page":"P1147","volume":"256","author":"H Itoh","year":"1991","unstructured":"Itoh H, Bunang RD. Cardiovascular and sympathetic effects of injecting serotonin into the nucleus tractus solitari in rats.Pharmacol Exp Ther 1991 Mar;256 (3): P1147\u20131153.","journal-title":"Pharmacol Exp Ther"},{"issue":"2","key":"BF01818888_CR20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0165-1838(93)90048-Y","volume":"42","author":"CJ Helke","year":"1993","unstructured":"Helke CJ, McDonald CH, Phillips ET. Hypotensive effects of 5-HT1A receptor activation: ventral medullary sites and mechanisms of action in the rat.J Auton Nerv Syst 1993;42 (2): 177\u2013188.","journal-title":"J Auton Nerv Syst"},{"issue":"6","key":"BF01818888_CR21","first-page":"421","volume":"46","author":"H Dabire","year":"1991","unstructured":"Dabire H. Central 5-hydroxytryptamine (5-HT) receptors in blood pressure regulation.Therapie 1991;46 (6): 421\u2013429.","journal-title":"Therapie"},{"issue":"6","key":"BF01818888_CR22","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/clpt.1993.89","volume":"53","author":"K Bauer","year":"1993","unstructured":"Bauer K, Dietersdorfer F, Kaik G. Assessment of \u00df-adrenergic receptor blockade after isamoltane, a 5-HT1 receptor active compound, in healthy volunteers.Clin Pharmacol Ther 1993;53 (6): 675\u2013683.","journal-title":"Clin Pharmacol Ther"},{"key":"BF01818888_CR23","first-page":"H496","volume":"255","author":"DA Morgan","year":"1988","unstructured":"Morgan DA, Thoren P, Wilczynski EA, Victor RG, Mark AL. Serotonergic mechanisms mediate renal sympathoinhibition during severe hemorrhage in rats.Am J Physiol 1988;255 (Heart Circ Physiol 24): H496-H502.","journal-title":"Am J Physiol"},{"issue":"6","key":"BF01818888_CR24","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/00005344-199206000-00025","volume":"19","author":"RG Evans","year":"1992","unstructured":"Evans RG, Kapoor V, Ludbrook J. A CNS serotonergic mechanism in acute central hypovolemia in conscious rabbits?J Cardiovasc Pharmacol 1992 Jun;19 (6): 1009\u20131017.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BF01818888_CR25","first-page":"234","volume":"2","author":"D Samoil","year":"1992","unstructured":"Samoil D, Grubb BP. Vasovagal (neurally mediated) syncope: pathophysiologic aspects.Eur J Cardiac Pacing Electrophysiol 1992;2: 234\u2013241.","journal-title":"Eur J Cardiac Pacing Electrophysiol"},{"key":"BF01818888_CR26","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1540-8159.1995.tb04666.x","volume":"18","author":"D Kosinski","year":"1994","unstructured":"Kosinski D, Grubb BP, Temesy-Armos P. Pathophysiological aspects of neurocardiogenic syncope: current concepts and new perspectives.PACE Pacing Clin Electrophysiol 1994;18: 716\u2013724.","journal-title":"PACE Pacing Clin Electrophysiol"},{"key":"BF01818888_CR27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1748-1716.1993.tb09609.x","volume":"149","author":"S Matzen","year":"1993","unstructured":"Matzen S, Secher NH, Knigge U, Pawelczyk J, Perko G, Iversen H, Bach FW, Warberg J. Effect of serotonin receptor blockade on endocrine and cardiovascular responses to head up tilt in humans.Acta Physiol Scand 1993;149: 163\u2013176.","journal-title":"Acta Physiol Scand"},{"key":"BF01818888_CR28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/bmj.304.6819.75","volume":"304","author":"I Pilgrim","year":"1992","unstructured":"Pilgrim I, Stansfeld S, Marmos M. Low blood pressure, low mood?BMJ 1992;304: 75\u201378.","journal-title":"BMJ"},{"key":"BF01818888_CR29","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1526-4610.1994.hed3407408.x","volume":"34","author":"SD Silberstein","year":"1994","unstructured":"Silberstein SD. Serotonin (5-HT) and migraine.Headache 1994;34: 408\u2013417.","journal-title":"Headache"},{"key":"BF01818888_CR30","first-page":"162","volume":"30","author":"B Shapira","year":"1994","unstructured":"Shapira B, Newman M, Lerer B. Serotonergic mechanisms in depression: clinical insights and biological correlates.Isr J Med Sci 1994;30: 162\u2013167.","journal-title":"Isr J Med Sci"},{"key":"BF01818888_CR31","first-page":"9","volume":"51","author":"K Rickels","year":"1990","unstructured":"Rickels K, Schweizer E. Clinical overview of the serotonin reuptake inhibitors.J Clin Psychiatr 1990;51: 9\u201312.","journal-title":"J Clin Psychiatr"},{"key":"BF01818888_CR32","first-page":"66","volume":"22","author":"S Rauch","year":"1992","unstructured":"Rauch S, Jenike M. Critical drug appraisal: fluoxetine.Drug Ther 1992;22: 66\u201380.","journal-title":"Drug Ther"},{"key":"BF01818888_CR33","first-page":"9","volume":"51","author":"K Rickels","year":"1990","unstructured":"Rickels K, Schweizer E. Clinical overview of serotonin reuptake inhibitors.J Clin Psychiatr 1990;51: 9\u201312.","journal-title":"J Clin Psychiatr"},{"issue":"3","key":"BF01818888_CR34","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1540-8159.1993.tb01608.x","volume":"16","author":"BP Grubb","year":"1992","unstructured":"Grubb BP, Wolfe DA, Samoil D, Temesy-Armos P, Hahn H, Elliot L. Usefulness of fluoxetine hydrochloride in the treatment of resistant upright tilt induced syncope.Pace 1992;16 (3): 458\u2013464.","journal-title":"Pace"},{"key":"BF01818888_CR35","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/0735-1097(94)90308-5","volume":"24","author":"BP Grubb","year":"1994","unstructured":"Grubb BP, Samoil D, Kosinski D, Kip K. The use of sertraline hydrochloride in the treatment of refractory neurocardiogenic syncope in children and adolescents.J Am Coll Cardiol 1994;24: 490\u2013494.","journal-title":"J Am Coll Cardiol"},{"key":"BF01818888_CR36","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1540-8159.1994.tb02379.x","volume":"17","author":"BD Williamson","year":"1994","unstructured":"Williamson BD, Strickberger A, Ching Man K, Hummel JD, Morady F. A randomized trial of sertraline versus atenolol and disopyramide in the treatment of neurocardiogenic syncope. (Abstr)PACE Pacing Clin Electrophysiol 1994;17: 747.","journal-title":"PACE Pacing Clin Electrophysiol"},{"key":"BF01818888_CR37","doi-asserted-by":"crossref","unstructured":"Kenny RA, Traynor G. Carotid sinus syndrome \u2014 clinical characteristics in elderly patients.Age Ageing 191;20: 449\u2013454.","DOI":"10.1093\/ageing\/20.6.449"},{"issue":"5","key":"BF01818888_CR38","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1161\/01.CIR.71.5.927","volume":"71","author":"A Almquist","year":"1985","unstructured":"Almquist A, Gormick C, Benson W, Dunnigan A, Benditt D. Carotid sinus hypersensitivity: evaluation of the vasodepressor component.Circulation 1985;71 (5): 927\u2013936.","journal-title":"Circulation"},{"key":"BF01818888_CR39","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/0002-9343(86)90417-1","volume":"81","author":"CS Zee-Cheng","year":"1986","unstructured":"Zee-Cheng CS, Gibbs HR. Pure vasodepressor carotid sinus hypersensitivity.Am J Med 1986;81: 1095\u20131097.","journal-title":"Am J Med"},{"key":"BF01818888_CR40","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1111\/j.1540-8159.1994.tb02463.x","volume":"17","author":"BP Grubb","year":"1994","unstructured":"Grubb BP, Samoil D, Kosinski D, Temesy-Armos P, Akpunonu B. The use of serotonin reuptake inhibitors for the treatment of recurrent syncope due to carotid sinus hypersensitivity unresponsive to dual chamber cardiac pacing.PACE Pacing Clin Electrophysiol 1994;17: 1434\u20131436.","journal-title":"PACE Pacing Clin Electrophysiol"},{"issue":"1","key":"BF01818888_CR41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/ageing\/22.1.53","volume":"22","author":"S McIntosh","year":"1993","unstructured":"McIntosh S, Da Costa D, Kenny RA. Outcome of an integrated approach to the investigation of dizziness, falls, and syncope in elderly patients referred to a syncope clinic.Age Aging 1993;22 (1): 53\u201358.","journal-title":"Age Aging"},{"key":"BF01818888_CR42","first-page":"423","volume-title":"Clinical Autonomic Disorders","author":"J Hilstead","year":"1993","unstructured":"Hilstead J, Low P. Diabetic autonomic neuropathy. In: Low P, ed.Clinical Autonomic Disorders. Boston: Little Brown and Company, 1993; 423\u2013444."},{"key":"BF01818888_CR43","first-page":"731","volume-title":"Clinical Autonomic Disorders","author":"R Fealey","year":"1993","unstructured":"Fealey R, Robertson D. Management of orthostatic hypotension. In: Low P, ed.Clinical Autonomic Disorders. Boston: Little Brown and Company, 1993; 731\u2013746."},{"key":"BF01818888_CR44","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0002-9343(94)90304-2","volume":"97","author":"BP Grubb","year":"1994","unstructured":"Grubb BP, Samoil D, Kosinski D, Wolfe DA. Fluoxetine hydrochloride for the treatment of severe refractory orthostatic hypotension.Am J Med 1994;97: 366\u2013368.","journal-title":"Am J Med"},{"key":"BF01818888_CR45","first-page":"707","volume":"265","author":"S Hjorth","year":"1993","unstructured":"Hjorth S, Sharp T.In vivo microdialysis evidence for central serotonin1A and serotonin1B autoreceptor blocking properties of the \u00df-adrenoceptor antagonist (\u2212) Penbutolol.J Pharmacol Exp Ther 1993;265: 707\u2013712.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF01818888_CR46","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0014-2999(92)90471-F","volume":"222","author":"S Hjorth","year":"1992","unstructured":"Hjorth S. Penbutolol as a blocker of central 5-HT1A receptor mediated responses.Eur J Pharmacol 1992;222: 121\u2013127.","journal-title":"Eur J Pharmacol"}],"container-title":["Clinical Autonomic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01818888.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01818888\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01818888","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T09:57:22Z","timestamp":1626083842000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01818888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,10]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1995,10]]}},"alternative-id":["BF01818888"],"URL":"https:\/\/doi.org\/10.1007\/bf01818888","relation":{},"ISSN":["0959-9851","1619-1560"],"issn-type":[{"value":"0959-9851","type":"print"},{"value":"1619-1560","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,10]]}}}